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Colorectal cancer is the third most commonly diagnosed cancer. Amongst treatments that have been explored, photodynamic
therapy (PDT) is a treatment that is of interest as it poses ideal advantages such as affinity for cancer cells. This study aimed to
determine the correlation between the localization site of a sulfonated zinc phthalocyanine (ZnPcSmix) photosensitizer (PS) and
its associated cell death pathway in vitro in colorectal cancer cell lines (DLD-1 and CaCo-2). Visible morphological changes were
observed in PDT treated cells after 24 h. Reactive oxygen species (ROS) were detected and visualized 1 h after PDT. ZnPcSmix was
predominantly localized in lysosomes and partially in themitochondria. FITCAnnexin V staining showed a significant decrease in
the percentage of viable DLD-1 and CaCo-2 cells 24 h after PDT, with an increase in apoptotic cell population. Moreover, there was
a significant increase in both cathepsin D and cytochrome C at 1 and 24 h. In conclusion, ZnPcSmix showed the ability of inducing
apoptotic cell death features in PDT treated cells.
1. Introduction
Cancer is defined as a group of diseases that have an
unbalanced rate between apoptosis and proliferation. Rapid
multiplication of abnormal cells may be caused by various
factors ranging from genetic to external factors such as chem-
icals or diet [1]. Colorectal cancer is amongst the top ranking
cancers that have a high mortality rate worldwide [1]. It
occurs as a result of genetic and epigenetic changes of normal
glandular epithelial cells into invasive adenocarcinoma [2].
The treatment for colorectal cancer remains a challenge due
to the highmetastatic incidence and recurrence of the disease
[3], as well as toxicity caused by chemotherapeutic drugs to
noncancerous cells. Colectomy, chemotherapy and radiation
are regarded as primary treatment methods. However, there
are concerns that these treatments commonly result in poor
quality of life, lower overall survival rate, and resistance to
treatment [4, 5]. Thus, it is essential to develop other thera-
peutic strategies that may potentially enhance the quality of
life and eventually improve survival rate.
Photodynamic therapy (PDT) has been under inves-
tigation as an alternative treatment modality to adjuvant
chemotherapy or chemoradiotherapy. PDT utilizes three
components, namely, light withwavelengths ranging between
650 and 750 nm, a photosensitive drug (referred to as a
photosensitizer, PS) capable of intracellular localization, and
molecular oxygen, which renders themodality effective [6]. It
is a comparatively bettermodality than surgery, radiotherapy,
and chemotherapy as it is a minimally invasive therapy. In
addition to being a minimally invasive treatment, a good
PS should possess a low dark (inactive) and administrative
toxicity [7]. Additionally, a well-formulated PS has a high
affinity for cancer cells due to the high content of low
density lipoprotein (LDL) receptors in cancer cells which
enhances uptake of the PS [8–10]. PDT is an ablative energy
requiring process that utilizes natural or synthetic structures
that are photosensitive and capable of absorbing energy in
the form of light. Castano et al. [7] suggested that an ideal
PS should absorb light in the red to near infrared spectra,
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as shorter wavelengths have lower tissue penetration capacity
[11, 12].
Although PDT was discovered over a century ago, it is
has become a field of interest with progressive developments
and advances, especially with regard to the development
of PSs. The photodynamic reaction occurs when the PS is
activated by absorption of energy from light (at a specific
wavelength) in the form of photons, thereby producing
reactive oxygen species (ROS) which then result in the
photodynamic reaction [13]. Light interaction with the PS is
one of the most crucial factors that determine the efficacy of
treatment [14].The photodynamic reaction can occur via two
known photochemistry pathways. The first pathway, usually
termed Type I, produces free radicals and ROS through
electron transfer between the PS triplet state and surrounding
molecules. The Type II reaction produces singlet oxygen
(1O
2
) through energy transfer from the PS ground state to
surrounding oxygen molecules [7, 15]. Both pathways can
occur concurrently, although the ratio may depend on the
type of PS, binding affinity of the substrate, and oxygen and
substrate concentration. However, the Type II reaction is
considered the most frequent pathway responsible for cell
death [14, 16–18].
Oxidative stress caused by PDT is known to cause mem-
brane lipid peroxidation or rupture and DNA damage that
may lead to apoptosis or necrosis [19]. Apoptosis occurs
through a series of intracellular and extracellular biochemical
milieu. Lysosomes and mitochondria are vital membranous
organelles that also play a role in cell death dynamics. PSs that
targetmitochondria have been thought to bemore effective as
opposed to those that localize in other organelles [20, 21] as it
is believed that they can induce apoptosis directly. However,
lysosomal targeting PSs have also been emerging as good
candidates [22, 23]. Lysosomes have an acidic environment
and host hydrolases that have the potential to degrade
proteins and the entire cell upon leakage [24]. Amongst well-
studied lysosomal hydrolases is cathepsin D which belongs
to the aspartyl proteases [25]. Besides its catalytic role,
cathepsin D also participates in apoptosis. When triggered
by cytotoxic factors, depending on the environment, it can
induce apoptosis or inhibit it [26, 27]. Permeabilization
of the lysosomal membrane can be activated by oxidative
stress which usually leads to mitochondrial outer membrane
destabilization and caspase activation through spillage of its
acidic contents or catalytic enzymes [28, 29]. Subsequently,
this may lead to leakage of cytochrome C frommitochondria
into the cytosol and thus activate caspases.
Cellular uptake of the PS is a fundamental factor in order
for the drug to be effective and its intracellular localiza-
tion site may help understand the mode of cell death as
molecular singlet oxygen may be primarily formed by PDT
in that preferred organelle. Zinc phthalocyanines (ZnPcs)
have desirable PDT application qualities as they are said
to have an intensive absorption of light in the visible red
region and high singlet and triplet production [30]. Barr et
al. used an aluminium sulphonated phthalocyanine (AlSPc)
for the treatment of dimethylhydrazine-induced colon cancer
in Wistar rats. They reported a significant eradication of the
colonic mucosa tumour with necrosis and further suggested
that it may be useful as an adjunctive treatment as they doubt
that PDTalonewill havemagnanimous effects for deep seated
tumours such as colon cancer in vivo [31]. Woodhams et
al. conducted a study using bacteriopherophorbide (Tookad)
based photodynamic therapy (PDT) in the colonic mucosa
of the Hooded Lister rats [32]. They reported short drug
light interval as an advantage; however, the treatment induced
necrosis accompanied by inflammatory response three days
after PDT [32].
In this study, we sought to determine the correlation
between the localization site of sulfonated zinc phthalocya-
nine (ZnPcSmix) in colorectal cancer cells (DLD-1 and CaCo-
2) and mode of cell death induced after PDT.
2. Materials and Methods
2.1. Cell Culture. This research was approved by the Aca-
demic Ethics Committee of the Faculty of Health Sciences,
University of Johannesburg, under ethics clearance number
AEC81/2009. Commercially obtained colorectal cancer cells
were used (CaCo-2 ATCC HTB-37 and DLD-1 ATCC CCL-
221). CaCo-2 cells were cultured in Dulbecco’s modified
Eagle’s media (DMEM, Sigma-Aldrich, D6429) with 1.2 g/L
sodium carbonate, supplemented with 10% foetal bovine
serum (FBS, Gibco, 306.00301), nonessential amino acids
(NEAA, Gibco, 11140), 0.5mM sodium pyruvate (Gibco,
11360), 2.5mM L-glutamine (Gibco, 25030), 1% antibiotic
(penicillin-streptomycin, Gibco, 15140), and 1% antifungal
(amphotericin-B, Gibco, 104813). DLD-1 cells were cultured
in Dulbecco’s modified Eagle’s media and Ham’s nutrient
mixture F-12 (DMEM/F12, Sigma-Aldrich, D6421), supple-
mented as for CaCo-2 cells. Cultures were maintained in
5% CO
2
and 85% humidity at 37∘C. Once cells reached 80–
90% confluence, they were harvested and seeded at a density
of 5 × 104 in 3mL media into sterile culture dishes, with a
diameter of 3.4 cm. Cells were allowed to attach overnight.
2.2. PDT Experiments. The ZnPcSmix used in this study
contained various sulfo groups that have been reported to
enhance the solubility [33]. The photochemical and photo-
physical properties of the ZnPcSmix in phosphate buffered
saline (PBS) were determined at the Department of Chem-
istry, Rhodes University, South Africa. ZnPcSmix had a fluo-
rescence quantum yield (Φ
𝐹
) of 0.16; triplet quantum yield
(Φ
𝑇
) of 0.53; singlet oxygen quantum yield (ΦΔ) of 0.45, and
triplet lifetime (𝜏
𝑇
) of 2.95 𝜇s [33]. Cells were divided into
three control groups: untreated cells, that is, cells that neither
received irradiation nor PS, cells receiving laser irradiation
alone (5 J/cm2), and cells receiving PS alone (ZnPcSmix) at a
concentration of 20𝜇M.The test group received both PS and
irradiation (PDT). Cells that did not receive laser irradiation
were sham irradiated. After cells had attached, they were
rinsed in Hank’s Balanced Salt Solution (HBSS, Invitrogen,
10-543F) and fresh media were added to a volume of 1mL
before the addition of ZnPcSmix or irradiation. Cells were
irradiated in the dark from above in an open culture dish,
using a continuous diode laser emitting light at a wavelength
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Table 1: Laser irradiation parameters.
Wavelength 680 nm
Average power output 42mW
Light source Diode
Illuminated area 9.1 cm2
Irradiance 4.6mW/cm2
Irradiation time 18min 6 s
Fluence 5 J/cm2
Power meter Coherent, fieldmate
of 680 nm; cells were irradiated with a fluence of 5 J/cm2,
as it was determined optimum from dose response studies
[34]. A combination of 20 𝜇M ZnPcSmix and a fluence of
5 J/cm2 was used based on the morphological changes that
resembled apoptosis as well as loss of cell viability beyond
40% as discussed in Manoto et al. [34]. Laser irradiation
parameters are tabulated in Table 1. Biological responses were
evaluated after further incubation for 1 or 24 h.
2.3. Cellular Morphology. The effect of the PS or PDT on
cell morphology was determined using an inverted light
microscope (Wirsam, Olympus CKX41). Once digital images
were recorded, cells were trypsinized using 1mL/25 cm2 of
TrypLE Express (Invitrogen, 12605-028) and resuspended in
HBSS (unless otherwise specified) to perform further assays.
2.4. Reactive Oxygen Species (ROS) Detection. Oxidative
stress caused by ZnPcSmix when activated by laser light was
shown qualitatively by fluorescent staining of the cells with
carboxy-H
2
DCFDA Reactive Oxygen Species detection kit
(Invitrogen, Image-iT, I36007). Cells cultured on cover slips
were washed with warm HBSS and covered with 25𝜇M
carboxy-H
2
DCFDA working solution and incubated for
30min at 37∘C in the dark. Thereafter, cells were washed
three times with HBSS and nuclei were counterstained with
0.1mg/mL of DAPI (4󸀠-6-diamidino-2-phenylindole, Sigma-
Aldrich, D9564) for 1min and washed. The ROS positive
control was prepared according to the protocol prescribed
by the manufacturer. Briefly, ROS was induced in CaCo-2
cells by adding 100 𝜇M of tert-butyl hydroperoxide (TBHP)
for duration of 1 h at 37∘C. Cells that received neither PDT
treatment, nor TBHP, nor laser irradiation were used as
negative controls. Cells were stained for ROS detection 1 h
after PDT by following the same procedure as mentioned
above. Fluorescence was visualized using a Carl Zeiss Axio
observer Z1 fluorescent microscope. Production of oxidation
by carboxy-H
2
DCFDA was viewed using 459Ex/529Em and
DAPI 350Ex/461Em filters.
2.5. Intracellular Localization of ZnPcSmix. Fluorescence
imaging was used to determine intracellular localization of
ZnPcSmix. Briefly, cells were cultured overnight on sterile
cover slips placed in 3.4 cm diameter culture dishes. Cells
were rinsed with warm HBSS before incubating with 1 𝜇M
ZnPcSmix in supplemented media for 1 h. Localization sites
of ZnPcSmix were determined using fluorescent markers for
intracellular organelles. For mitochondria, cells were stained
with 50 nMMitoTracker Green FM (Invitrogen, M7514) and
75 nM LysoTracker Green DND-26 (Invitrogen, L7526) was
used for lysosomes. Cells were then incubated for 15min in
the dark. Nuclei were counterstained with DAPI. Fluores-
cence was visualized using a Carl Zeiss Axio observer Z1
fluorescent microscope [34].
2.6. Lysosomal Cathepsin D. Lysosomal protease cathepsin
D was measured using an enzyme-linked immunosorbent
assay (ELISA) kit (Biocombiotech, Cusabio Biotech, CSB-
E09221h). Standard, blank (media only), or supernatants
from experimental cells were added to their respective wells
to a final volume of 100 𝜇L. The plate was then incubated
for 2 h at 37∘C. Wells were aspirated and 100 𝜇L of biotin-
antibodyworking solution was added to each well and incu-
bated for 1 h at 37∘C. Eachwell was aspirated andwashedwith
washing buffer three times. Horseradish peroxide- (HRP-)
avidin working solution was then added to each well, and the
platewas incubated for 1 h at 37∘C.Theplatewas aspirated and
washed three times and then tetramethylbenzidine (TMB)
substrate was added and incubated for 30min at 37∘C.
Stop solution was added and the plate was read at 450 nm
absorbance using the Victor 3 multilabel microplate reader
(Perkin-Elmer).
2.7. Cytosolic Cytochrome C. Cytosolic human cytochrome
C was measured by ELISA (Biocombiotech, eBioscience,
BMS263/BMS263TEN). Cell lysates were prepared according
to the manufacturer’s protocol. Briefly, cells were centrifuged
at 137×g for 15min and washed with cold PBS. Cells were
then resuspended in lysis buffer at a concentration of 1.5 ×
106 per 1mL and incubated at room temperature for 1 h with
gentle shaking (10 rpm) using an orbital shaker (Labotech,
Heidolph, Polymax 1040). Cells were then centrifuged at
200×g for 15min. The supernatant was diluted 50-fold in
assay buffer.Wells werewashedwith 400𝜇L ofwashing buffer
prior to commencing. Samples and standards were added
to their respective wells and biotin-conjugate was added.
The plate was incubated at room temperature for 2 h and
then washed as before. Streptavidin-HRP was added and
incubated for 1 h at room temperature. Thereafter, the plate
was washed and TMB substrate was added for approximately
10min and the reaction was stopped. Absorbance was read
at 450 nm using the Victor [3] multilabel microplate reader
(Perkin-Elmer).
2.8. FITC Annexin V. To determine the mode of cell death
(necrosis or apoptosis), FITC Annexin V stain was used and
the fluorescencewas read using a flow cytometer (FACSAria).
FITC Annexin V was used in conjunction with propidium
iodide (PI) vital stain for necrotic cells. Cells were stained by
washing detached cells twice with cold PBS and resuspended
in 500𝜇L of 1x assay binding buffer. A volume of 100𝜇L was
transferred into a 5mL culture tube and incubated with 5 𝜇L
of FITC Annexin V and another 5 𝜇L of PI. Cells were mixed
by vortexing and incubated for 5min on ice away from direct
light. Then 400 𝜇L of 1x binding buffer was added to all the
4 International Journal of Photoenergy
samples and were analyzed on the FACSAria flow cytometer
by reading 10 000 events.
2.9. Statistical Analysis. Each experiment was repeated four
times (𝑛 = 4). Biochemical assays were done in duplicate
and an average of the results was used. Statistics were
analyzed using the SigmaPlot software version 8.0 (Systat
Software) and the mean, standard deviation, standard error,
and significant changes were calculated. Student 𝑡-test and
one-wayANOVAwere performed to determine the statistical
difference between the controls and the experimental group.
Statistical differences are shown in graphs as (∗)𝑃 < 0.05, (∗∗)
𝑃 < 0.01, and (∗∗∗) 𝑃 < 0.001 and dispersion bars represent
standard error.
3. Results and Discussion
3.1. Cellular Morphology. Control cells did not show any
morphological changes at both 1 and 24 h incubation periods
(Figure 1). After 1 h incubation, morphology of PDT treated
CaCo-2 cells appeared altered as compared to control cells.
PDT treated cells appeared less uniform with loss of mem-
brane integrity, although still intact; this was not observed
in the DLD-1 cell line. Furthermore, after 24 h significant
changes were noticed whereby cells appeared pyknotic, intact
membrane, and condensed nuclei. Some cells had detached
from the culture plate and lost their original morphological
features compared to those incubated for 1 h and the control
cells.
We have previously shown that DLD-1 colorectal cancer
cells are sensitive to ZnPcSmix alone and PDT using the same
PS [34]. The morphological features of DLD-1 and CaCo-
2 control cells (untreated; 5 J/cm2 or ZnPcSmix) remained
unchanged. However, morphological changes in the cells
that received PDT treatment resembled that of apoptotic
features as seen by the cells detaching from the culture dish
surface, cellular shrinking, and an intact membrane [34].
Nonetheless, based on these morphological findings, it is not
conclusive that the cells were definitely undergoing apoptosis.
3.2. Reactive Oxygen Species (ROS) Detection. ROS such as
hydroxyl radicals (∙OH) and hydrogen peroxide (H
2
O
2
) are
normally generated in small amounts in cellular organisms
due to aerobic metabolism [34]. However, oxidative stress
caused by increased ROS concentration is known to cause
cellular damage, and ROS induction has also been implicated
in apoptosis [35, 36]. ROS were detected in both cell lines
that were treated with PDT as shown by distinct green
fluorescence in the cytoplasm (Figure 2). PDT treated cells
showed ROS fluorescence intensity similar to that of the
positive control, thus proving that there was photooxidation
after PDT. Based on this observation, we could anticipate that
cell damage will follow eventually as ROS are known to kill
cells by oxidizing lipidmembranes and biomolecules [37, 38].
Thiswas shownby the time dependent loss of cellular viability
seen in PDT treated cells resulting in more than 40% cell
death [34].
3.3. Intracellular Localization of ZnPcSmix. It is known that
the localization site of a PS is of importance as it is indicative
of where the initial damage will occur [20, 39]. When
cells were visualized using fluorescent microscopy, ZnPcSmix
predominantly localized in the lysosomes and to a lesser
extent in the mitochondria (Figure 3).
Kessel and Luo deduced from their research that sub-
cellular localization of the PS is a primary determinant of
the cell death mechanism in PDT. Since the PS used in this
study localizes predominantly in lysosomes and minimally
in mitochondria, it is suggestive that ZnPcSmix has chemical
properties or charge that target both lysosomes and mito-
chondria [40]. A study conducted by Kessel and Luo used
two Zn based phthalocyanine PSs in human cervical squa-
mous carcinoma (HeLa) and murine colon adenocarcinoma
(CT26) cells; one was cationic and the other was anionic
[41]. The cationic porphyrin PS was more effective than the
anionic PS as the former localized in both lysosomes and
mitochondria. They further reported enhanced efficacy at
concentrations between 2 and 10𝜇M for the cationic PS and
10 and 50 𝜇M for the anionic PS, both activated at a fluence
of 10 J/cm2. However, CT26 cells were not sensitive enough
to the initial concentration of 5𝜇M cationic PS that was
activated with 20 J/cm2, although HeLa cells were sensitive
[41]. Since our results coincidewithMroz et al.’s results, itmay
be suggested that the PDT of colon adenocarcinoma using
phthalocyanines may require high dosage in order to render
the therapy beneficial, provided that the PS has significantly
low dark toxicity.
3.4. Lysosomal Cathepsin D. At both time points, cathepsin
D in DLD-1 and CaCo-2 cells that received irradiation alone
(5 J/cm2) did not result in significant changeswhen compared
to untreated control cells, Table 2. After 1 h incubation,
cathepsin D release was significantly increased in DLD-1 cells
incubated with ZnPcSmix alone (𝑃 < 0.05) or those that
received PDT (𝑃 < 0.01) in comparison to untreated control
cells. A significant change was also noted in CaCo-2 cells
that received PDT compared to controls that were untreated
or irradiated (5 J/cm2) (𝑃 < 0.01) and those that received
ZnPcSmix alone (𝑃 < 0.05) after 1 h incubation. Comparing
cathepsin D in PDT treated DLD-1 and CaCo-2 cells after
1 h incubation revealed a significant increase in CaCo-2 cells
(𝑃 < 0.05).
After 24 h, both DLD-1 and CaCo-2 PDT treated cells
had a significant increase in cathepsin D release (𝑃 < 0.001)
when compared to all control cells (untreated, 5 J/cm2 and
ZnPcSmix). Additionally, after 24 h, ZnPcSmix alone induced
a significant increase in cathepsin D release in CaCo-2 cells
when compared to cells that received irradiation alone (𝑃 <
0.05). Cathepsin D release in PDT treated DLD-1 cells had
significantly increased after 24 h incubation in comparison to
1 h incubation (𝑃 < 0.01). Moreover, there was a significant
difference betweenDLD-1 andCaCo-2 PDT treated cells after
24 h incubation (𝑃 < 0.05).
Assuming that a high concentration of ROS is formed
around the lysosomes, increased amounts of H
2
O
2
can
International Journal of Photoenergy 5
50𝜇m50𝜇m
Untreated PDT5 J/cm2 ZnPcSmix
1
h
D
LD
-1
D
LD
-1
2
4
h
1
h
Ca
C
o-
2
Ca
C
o-
2
2
4
h
0.0005 pixel 0.0005 pixel 0.0005 pixel 0.0005 pixel
0.0005 pixel 0.0005 pixel 0.0005 pixel 0.0005 pixel
50𝜇m 50𝜇m
50𝜇m 50𝜇m 50𝜇m 50𝜇m
Figure 1: Morphology of DLD-1 and CaCo-2 cells after 1 or 24 h after PDT. After 1 h incubation after PDT, there were no significant visible
differences in both DLD-1 and CaCo-2 cells, but, to some extent, cells showed membranal irregularity. After 24 h incubation, PDT cells
appeared shrunken and rounded and had detached.
diffuse into lysosomes and react with intralysosomal met-
alloproteins (iron containing proteins) that have degraded
as a result of acidic pH. Iron is then reduced and hydroxyl
radicals are formed which promote lipid peroxidation, caus-
ing leakage of lysosomal contents [42]. Therefore, perhaps
the cell death mechanism induced in the DLD-1 and CaCo-2
cells after PDT could primarily be initiated from lysosomes.
Mroz et al. reported that lysosomalmembrane destabilization
is an early event in apoptosis as compared to mitochondrial
membrane destabilization [43]. However, even if photodam-
age is initiated in the lysosomes, the mitochondrial pathway
is responsible for cell death as the activation of Bid is as a
result of lysosomal protease release as hypothesized by Kurz
and colleagues, in their study that also used a phthalocyanine
PS that localized in lysosomes [44]. Our findings are in
accordance with Kurz and colleagues’ findings [44].
Based on the localization pattern of the ZnPcSmix, we
determined that there was a proteolytic release of lysosomal
aspartate cathepsin D, which is associated with cell death
[45]. Oxidative stress can directly disrupt the lysosomal
membrane. It has been hypothesized that limited release of
lysosomal contents can trigger apoptosis or apoptosis-like cell
death as opposed to generalized membrane rupture which
may cause necrosis [46, 47]. In our study we found that there
was a significant release of cathepsin D in both PDT treated
cell lines especially after 24 h incubation. However, ZnPcSmix
alone also induced a significant leakage of the aspartic
enzyme after 1 h incubation inDLD-1 cells and 24 h inCaCo-2
cells in comparison to sham irradiated control cells, although
it was to a lesser extent. This could be due to the prolonged
incubation with the PS which may eventually lead to osmotic
stress and can trigger membrane permeabilization [37].
3.5. Cytosolic Cytochrome C. Relocation of mitochondrial
cytochrome C to the cytosol was quantitatively determined
by ELISA in order to investigate mitochondrial membrane
destabilization, as it is a hallmark of apoptosis. DLD-1 cells
exposed to ZnPcSmix alone proved to be susceptible to the
photosensitizer at a concentration of 20𝜇M, and there was
a significant increase in cytochrome C when compared to
untreated control cells after 1 h incubation (𝑃 < 0.001),
Table 2. There was a significant relocation of cytochrome C
to the cytosol in PDT treated DLD-1 and CaCo-2 cells at
both 1 and 24 h incubation (𝑃 < 0.001) when compared to
all the control groups. Comparison of the incubation times
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Figure 2: ROS production was qualitatively detected by staining cells with carboxy-H
2
DCFDAwhich appears as green fluorescence if present
as pointed out by the arrows. Nuclei were counterstained with DAPI (blue).
showed that there was a significant increase (𝑃 < 0.01) in
cytochrome C in PDT treated cells (DLD-1 and CaCo-2) at
24 h compared to 1 h. When DLD-1 and CaCo-2 cells that
were incubated with ZnPcSmix alone were compared after 1 h
incubation, there was a significant difference (𝑃 < 0.05) in
cytochrome C release. However, the difference was not seen
after 24 h incubation.
These results are in agreement with the cathepsin D
results, denoting that the mitochondrial membrane is desta-
bilized by lysosomal enzymes. This is supported by the idea
proposed by Brunk and Svensson that lysosomal proteases
can cause direct detrimental damage to the mitochondrial
membrane [48]. The release of cytochrome C is believed to
be an important event in PDT induced apoptosis as a result
of ROS damage produced at the localization site [49, 50].
3.6. FITC Annexin V. There was a significant increase in the
number of apoptotic DLD-1 cells as compared to the viable
population 1 h after PDT (𝑃 < 0.001), Figure 4(a). Incubation
of DLD-1 cells 24 h after PDT also showed a significant
increase in apoptotic cells as compared to the viable and
necrotic population (𝑃 < 0.001). Similarly, a significant
increase was also seen compared to the apoptotic population
in control cells (𝑃 < 0.001). There was a significant decrease
in the percentage of viable PDT treated CaCo-2 cells after
1 h incubation as compared to the same cell population in
control cells (𝑃 < 0.001), Figure 4(b). When the apoptotic
population in PDT treated CaCo-2 cells was compared to the
viable and necrotic population within the same group, there
was a significant increase in apoptosis at 1 and 24 h after PDT
incubation (𝑃 < 0.001).
Incubation with PS alone appeared to be a crucial factor
for cell toxicity, as longer incubation periods may have
resulted in unnecessary toxicity, rendering dosimetry a fun-
damental component of the treatment of colorectal cancer.
This was proven otherwise by the FITC Annexin V results
which showed that ZnPcSmix in its inactive form was inef-
fective in inducing necrotic or apoptotic cell death as there
was a fair amount of dead cells similar to untreated control
cells. Activation of ZnPcSmix potentially resulted in cell death
and confirmed that the prevailing mode of cell death after
PDT was apoptosis. Our results suggest that the apoptotic
cell death pathway is initiated by lysosomes which prompts
delayed mitochondrial cytochrome C leakage as induced by
the proteolytic enzyme cathepsinD aswell as the lowpH from
lysosomes in response to PDT. Moreover, it is possible that
the mitochondrial membrane could be directly destabilized
International Journal of Photoenergy 7
ZnPcSmixDAPI Organelle Merged
Ly
so
so
m
es
M
ito
ch
on
dr
ia
50𝜇m
50𝜇m
50𝜇m 50𝜇m
50𝜇m 50𝜇m 50𝜇m 50𝜇m
(a)
ZnPcSmixDAPI Organelle Merged
M
ito
ch
on
dr
ia
Ly
so
so
m
es
20𝜇m 20𝜇m 20𝜇m 20𝜇m
20𝜇m 20𝜇m
20𝜇m 20𝜇m
(b)
Figure 3: Intracellular localization of ZnPcSmix PS in DLD-1 and CaCo-2 cells. PS localized in lysosomes in both cell lines as seen by the
merging red and green colours as pointed out by the arrows. In mitochondria, there was an indefinite localization pattern. However, the
orange colour meant that there was PS in mitochondria, as pointed out by the arrows. Nuclei were stained with DAPI (blue).
Table 2: Cathepsin D and cytosolic cytochrome C were measured after 1 and 24 h incubation after PDT. Significant differences shown in
the table represent comparison between PDT treated cells and their respective untreated control cells after 1 or 24 h incubation (∗𝑃 < 0.05;
∗∗𝑃 < 0.01, and ∗∗∗𝑃 < 0.001). Cathepsin D was significantly increased in DLD-1 (𝑃 < 0.01) and CaCo-2 (𝑃 < 0.05) after 24 h incubation
in comparison to after 1 h incubation. In both cell lines, cytochrome C was significantly increased after 24 h incubation as compared to 1 h
incubation (𝑃 < 0.01).
Assay Time Untreated 5 J/cm
2 ZnPcSmix PDT
DLD-1 CaCo-2 DLD-1 CaCo-2 DLD-1 CaCo-2 DLD-1 CaCo-2
Cath-D 1 h 0.05
a ± 1.16b 0.06 ± 2.84 0.06 ± 2.52 0.06 ± 1.78 0.06∗ ± 9.76 0.07∗ ± 2.28 0.07∗ ± 3.82 0.08∗∗ ± 4.31
24 h 0.06 ± 2.39 0.07 ± 1.31 0.06 ± 3.03 0.06 ± 9.38 0.07 ± 5.12 0.07 ± 2.02 0.10∗∗∗ ± 2.78 0.09∗∗∗ ± 3.89
Cyto-C 1 h 0.10 ± 2.194 0.24 ± 0.15 0.12 ± 0.02 0.11 ± 0.01 0.20
∗∗∗
± 0.03 0.11 ± 0.02 2.41
∗∗∗
± 0.12 2.22
∗∗∗
± 0.18
24 h 0.09 ± 4.33 0.09 ± 4.57 0.12 ± 0.01 0.09 ± 5.47 0.27 ± 0.09 0.14 ± 0.02 3.14∗∗∗ ± 0.22 3.05∗∗∗ ± 0.22
aMean; bstandard error of mean (SEM).
by ROS that are formed immediately at the localization site
and the acidic milieu from the lysosomal compartments.
Furthermore, the fact that ZnPcSmix activation can induce
lysosomal rupture, thereby releasing cathepsin D, renders
ZnPcSmix an interesting and effective PS since it can localize
in two vital organelles. Work conducted by Oleinick’s group
also affirmed that the lysosomal targeted phthalocyanine
PSs (Pc181) was surprisingly effective as opposed to the
mitochondrial targeted PSs [39].
It is not clear from these results which subcellular
organelle can be held responsible for cell death initiation,
so further work needs to be conducted to determine which
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Figure 4: FITC Annexin V staining was used for the assessment of cell death mode in DLD-1 (a) and CaCo-2 (b) cells. Significant differences
as compared to untreated cells are shown as ∗∗∗𝑃 < 0.001. After 24 h, there was a significant increase in the percentage of apoptotic cell
population compared to 1 h incubation in PDT treated DLD-1 cells (a). PDT treated CaCo-2 cells (b) had a significantly increased apoptotic
population percentage after both 1 and 24 h incubation compared to their respective viable or necrotic cell population percentage (𝑃 < 0.001).
subcellular organelle is responsible for dissemination of cell
death signals.
4. Conclusion
Despite the fact that the same PS was used on two different
colorectal cancer cells, these cell lines responded differently.
It is evident that the CaCo-2 cells are more susceptible to
PDT than the DLD-1 cells. This could be explained by the
different cancer stages that these cells are in CaCo-2 cells are
at Duke’s B stage (well differentiated, less tumourigenic, and
invasive), while DLD-1 cells are at Duke’s C stage (metastatic
and involves one or three regional lymph nodes). Thus the
stage of cancer should be taken into consideration when
International Journal of Photoenergy 9
conducting such experiments. We hypothesize that ZnPcSmix
is capable of inducing apoptotic cell death that is promoted
by lysosomal photooxidation. The mechanism in which this
PS induces cell death needs to be further studied in order to
understand how it triggers cell death, from which initiation
point cell death is triggered and how the various cancer stages
respond to the treatment.
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